• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用阴茎中央海绵体动脉进行显微外科阴茎血管重建术。

Microsurgical penile revascularization using the central corporeal penile artery.

作者信息

Konnak J W, Ohl D A

机构信息

Department of Surgery, University of Michigan Medical Center, Ann Arbor.

出版信息

J Urol. 1989 Aug;142(2 Pt 1):305-8. doi: 10.1016/s0022-5347(17)38740-2.

DOI:10.1016/s0022-5347(17)38740-2
PMID:2746748
Abstract

We treated 9 patients with vasculogenic impotence by penile revascularization using a microsurgical anastomosis between the inferior epigastric artery and the central corporeal penile artery. Diagnostic evaluation included penile brachial indexes and pelvic arteriograms, which were abnormal in all 9 patients. Revascularization was technically possible in 7 of 9 patients; 2 had inadequate central arteries. The penile brachial index initially was improved in all 7 patients, although 1 had an early occlusion at 2 months and 1 had a late occlusion at 4 years. Potency was improved initially in 6 of the 9 patients, with longer term improvement in 5 of 9 followed 1 to 8 years. Two patients remain potent currently. The advantages of this technique are a reasonably high technical success rate in selected patients, with improved initial potency in more than half. The disadvantages include technical difficulty, lack of clear-cut selection criteria and unknown long-term results.

摘要

我们采用显微外科技术将腹壁下动脉与阴茎海绵体中央动脉进行吻合,对9例血管性阳痿患者实施阴茎血运重建术。诊断评估包括阴茎肱动脉指数和盆腔动脉造影,9例患者的检查结果均异常。9例患者中有7例在技术上可行血运重建术;2例中央动脉不足。7例患者的阴茎肱动脉指数最初均有所改善,不过1例在2个月时出现早期闭塞,1例在4年时出现晚期闭塞。9例患者中有6例最初性功能得到改善,9例中有5例在随访1至8年后获得长期改善。目前有2例患者仍保持性功能。该技术的优点是在选定患者中技术成功率较高,超过半数患者的初始性功能得到改善。缺点包括技术难度大、缺乏明确的选择标准以及长期效果不明。

相似文献

1
Microsurgical penile revascularization using the central corporeal penile artery.使用阴茎中央海绵体动脉进行显微外科阴茎血管重建术。
J Urol. 1989 Aug;142(2 Pt 1):305-8. doi: 10.1016/s0022-5347(17)38740-2.
2
Microvascular treatment of impotence.阳痿的微血管治疗
Plast Reconstr Surg. 1993 Jan;91(1):99-102. doi: 10.1097/00006534-199301000-00015.
3
Microscopic penile revascularization.显微阴茎血管重建术。
J Urol. 1983 Mar;129(3):517-21. doi: 10.1016/s0022-5347(17)52211-9.
4
The success of microsurgical penile revascularization in treating arteriogenic impotence.
Int J Impot Res. 1993 Mar;5(1):47-52.
5
Microsurgical arteriovenous revascularization in the treatment of vasculogenic impotence.显微外科动静脉血运重建术治疗血管性阳痿
J Urol. 1992 Apr;147(4):1028-31. doi: 10.1016/s0022-5347(17)37455-4.
6
Microsurgical arterio-arterial and arterio-venous penile revascularization in patients with pure arteriogenic impotence.单纯动脉性阳痿患者的显微外科动脉-动脉和动脉-静脉阴茎血运重建术
Br J Urol. 1994 May;73(5):561-5. doi: 10.1111/j.1464-410x.1994.tb07644.x.
7
Penile revascularization in the treatment of impotence.阴茎血管重建术治疗阳痿。
West J Med. 1981 Mar;134(3):206-11.
8
Penile revascularization in nonresponders to intracavernous injections using a modified microsurgical technique.
Eur Urol. 1992;21(2):120-5. doi: 10.1159/000474816.
9
Cavernous artery revascularization in vasculogenic impotence: new simplified technique.血管性阳痿的海绵体动脉血运重建:新的简化技术
Urology. 1987 Jul;30(1):23-6. doi: 10.1016/0090-4295(87)90564-4.
10
[Diagnosis and microsurgical correction of impotence of vascular origin].
Khirurgiia (Mosk). 1990 May(5):113-9.

引用本文的文献

1
Sexual function outcomes following fracture of the penis.阴茎骨折后的性功能结果。
Can Urol Assoc J. 2013 Jul-Aug;7(7-8):252-7. doi: 10.5489/cuaj.199.
2
Penile fracture with bilateral corporeal rupture and complete urethral disruption: case report and literature review.阴茎骨折伴双侧海绵体破裂及完全性尿道断裂:病例报告及文献综述
Can Urol Assoc J. 2011 Apr;5(2):E23-6. doi: 10.5489/cuaj.10055.
3
An overview of the diagnosis and treatment of erectile dysfunction.勃起功能障碍的诊断与治疗概述
Drugs. 2006;66(18):2339-55. doi: 10.2165/00003495-200666180-00006.